Sort by:

select Language:

Roadmap for introduction and roll‐out of Merck rVSV‐ZEBOV Ebola Virus Disease vaccine in African countries

World Health Organization WHO, (2019)

Revised working paper following AVAREF meeting February 2019. WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epidemic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo. WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.

Regional Ebola Preparedness Overview of Needs and Requirements June to December 2019

World Health Organization WHO, (2019)

This document presents a consolidated summary of urgent activities required to advance preparedness, as elaborated in each country's national plan, with a particular focus on Priority 1 countries. It presents the estimated requirements, needs, and gaps for each of the Priority 1 countries and a summary for Priority 2 countries, as aligned for the period of July to December 2019.

Social Science in Humanitarian Action Key considerations: Ebola preparedness and readiness in Goma, DRC

Peyton, D.; I. Gercama and J. Bedford, Eds.: Social Science in Humanitarian Action: A Communication for Development Platform, (2019)

This brief summarises key considerations about the social, political and economic context of Goma in relation to the outbreak of Ebola in the DRC as of March 2019. Goma is the administrative capital of North Kivu province and a major urban centre in the Great Lakes Region. The city is home to an estimated 1.5 million people and serves as an important economic and transportation hub that links eastern Congo to the broader East African sub-region. The arrival of Ebola in Goma would substantially increase the at-risk population and heighten the potential for cross-border transmission to neighbouring countries, particularly Rwanda. This brief therefore focuses on local social and political structures that can be leveraged to promote preparedness and readiness actions.

WHO Regional strategic plan for EVD operational readiness and preparedness in countries neighboring the Democratic Republic of the Congo June 2018 – February 2019

World Health Organization WHO, (2018)

The Strategic plan aims to ensure alignment of preparedness and readiness actions in the nine countries focusing on eight technical areas: strengthening multisectoral coordination; surveillance for early detection; laboratory diagnostic capacity; points of entry; rapid response teams; risk communication, social mobilization and community engagement; case management and infection prevention and control (IPC) capacities; and, operations support and logistics. The purpose of the WHO Regional Strategic Plan is to ensure that the countries bordering the Democratic Republic of the Congo are prepared and ready to implement timely and effective risk mitigation, detection and response measures should there be any importation of EVD cases.

Ebola: Prise en charge clinique des cas d'Ebola

Organisation Mondiale de la Santé OMS, (2018)

Aperçu: Cette formation complète de niveau intermédiaire est destinée aux agents de santé de première ligne qui s’occupent de cas suspects ou confirmés de maladie à virus Ebola (MVE). Elle porte sur les domaines suivants : transmission de la MVE (en s’intéressant en particulier aux mesures de lutte contre l’infection) ; diagnostic de la maladie ; et prise en charge des cas, avec une présentation générale des centres de traitement d’Ebola (CTE) et des informations sur les traitements expérimentaux. Ces modules présentent des stratégies complètes sur la sécurité des patients et des agents de soins et la préparation à la riposte. La formation pourra être utile aux cliniciens de tout secteur du système de santé, notamment ceux qui travaillent dans des postes de santé, prodiguent des soins de santé primaires ou sont employés par des hôpitaux nationaux ou de district. Une attention particulière est accordée aux soins dispensés dans les CTE. Objectifs d’apprentissage : À la fin de ce cours, vous serez capable de : identifier les patients présentant des signes et des symptômes de MVE ; comprendre la transmission de la MVE ; comprendre les grands volets de la prise en charge clinique de la MVE ; connaître les stratégies de lutte contre l’infection; préparer les établissements, la population et les agents de santé à la riposte à la maladie à virus Ebola ; et gérer les déchets de façon sécurisée et de procéder à des inhumations sans risque et dans la dignité. Durée du cours : Environ 8 heures. Enroll:

47 hits